Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eaton Vance Ohio Municipal Income Trust (NQ: EVO ) 3.430 +0.070 (+2.08%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Eaton Vance Ohio Municipal Income Trust < Previous 1 2 3 4 5 6 7 Next > Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022 April 05, 2022 HAMBURG, GERMANY / ACCESSWIRE / April 5, 2022 / Evotec SE (Frankfurt Stock Exchange:EVT, MDAX/TecDAX, ISIN: DE0005664809); (NASDAQ:EVO) will announce its financial results for 2021 on Tuesday, 12 April... From Evotec AG Via AccessWire TYME Technologies Reviews Potential Strategic Options March 29, 2022 Via Benzinga Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme March 21, 2022 - FIRST DOSING OF A STUDY PARTICIPANT TRIGGERS MILESTONE PAYMENT OF € 3 M TO EVOTEC - PHASE II CLINICAL TRIAL INITIATED BY EVOTEC'S PARTNER BAYER TO EVALUATE BAY 2395840 AS A POTENTIAL TREATMENT FOR... From Evotec AG Via AccessWire Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day March 02, 2022 - LAUNCH OF E.MPD, THE LEADING GLOBAL MOLECULAR PATIENT DATABASE - ROLL-OUT AND ACCELERATION OF AI/ML PRECISION TECHNOLOGIES TO INCREASE PROBABILITY OF SUCCESS ("POS") IN RESEARCH, DEVELOPMENT, AND... From Evotec AG Via AccessWire Topics Artificial Intelligence Exposures Artificial Intelligence Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol March 01, 2022 - EVOTEC RECEIVES ACCESS TO AN INTERNATIONAL COHORT OF NEPHROTIC SYNDROME PATIENTS COORDINATED BY THE UNIVERSITY OF BRISTOL - THE COHORT PROVIDES LONGITUDINAL ACCESS NOT ONLY TO CLINICAL DATA BUT IN... From Evotec AG Via AccessWire Stocks That Hit 52-Week Lows On Monday February 07, 2022 On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (... Via Benzinga 50 Biggest Movers From Friday February 07, 2022 Also check out this: Executives Sell Over $45M Of 5 Stocks Losers Ra Medical Systems, Inc. (NYSE: RMED) shares dipped 48.8% to close at $0.3599 on Friday after the... Via Benzinga Why Are Evotec Shares Trading Lower On Friday? February 04, 2022 Bayer AG (OTC: BAYRY) has Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session February 04, 2022 Gainers iRadimed (NASDAQ:IRMD) stock rose 15.0% to $45.19 during Friday's regular session. Trading volume for iRadimed's stock is 94.1K as of 12:30 EST. This is... Via Benzinga Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets February 04, 2022 HAMBURG, GERMANY / ACCESSWIRE / February 4, 2022 / Evotec SE (Frankfurt Stock Exchange, MDAX/TecDAX, ISIN: DE 000 566480 9, WKN 566480; NASDAQ) announces today that the Company has been informed by... From Evotec AG Via AccessWire The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data January 25, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Pfizer, BioNTech Initiates Study Of Omicron-Based Vaccine Candidate Pfizer,... Via Benzinga Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology January 25, 2022 - PARTNERSHIP LEVERAGES EVOTEC'S HUMAN IPSC-BASED PHENOTYPIC SCREENING AND PANOMICS PLATFORMS - AIM IS TO IDENTIFY AND VALIDATE PROMISING TARGETS AND NEW APPROACHES FOR THERAPEUTIC INTERVENTIONS... From Evotec AG Via AccessWire Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases January 18, 2022 - COLLABORATION LEVERAGES EVOTEC'S BROAD METABOLIC EXPERTISE AND UNIQUE KIDNEY DISEASE PATIENT DATABASE AS WELL AS INTEGRATED DATA-DRIVEN DRUG DISCOVERY AND DEVELOPMENT PLATFORMS - LILLY HAS THE RIGHT... From Evotec AG Via AccessWire From Mobile Clinics to Drug Development, This Company Is Attempting to Tackle Brain Disorders and Promote Mental Health Advances January 05, 2022 Photo by David Matos on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial... Via Benzinga Maravai Lifesciences Stock Closes In Technical Benchmark, Hitting 80-Plus RS Rating January 03, 2022 One key metric to look for in a stock is 80-plus RS Rating. Maravai Lifesciences stock just hit that mark, with a jump from 71 to 81 Monday. Via Investor's Business Daily Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic January 03, 2022 - EVOTEC RECEIVES A € 7.5 M GRANT FROM THE GERMAN FEDERAL MINISTRY OF EDUCATION AND RESEARCH ("BMBF") FOR THE DEVELOPMENT OF A THERAPEUTIC AGAINST COVID-19 - EVOTEC IS DEVELOPING A HIGHLY POTENT... From Evotec AG Via AccessWire Exposures COVID-19 Composite Rating For Regeneron Stock Rises To 96 December 09, 2021 Regeneron stock saw its IBD SmartSelect Composite Rating rise to 96 Thursday, up from 93 the day before for the New York firm. Via Investor's Business Daily Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2021 November 29, 2021 Upgrades According to Odeon Capital, the prior rating for Wells Fargo & Co (NYSE: Via Benzinga The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week November 28, 2021 Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses... Via Benzinga Exposures COVID-19 Product Safety EXCLUSIVE: This Company Hopes to Take an Innovative Approach To Treat Addiction November 19, 2021 Photo by Myriam Zilles... Via Benzinga EQRx and Evotec Announce Integrated Drug Discovery and Development Partnership November 18, 2021 From EQRx Via Business Wire Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership November 18, 2021 - EQRX TO LEVERAGE EVOTEC'S UNIQUE DATA-DRIVEN INTEGRATED DRUG DISCOVERY AND DEVELOPMENT ACCELERATOR PLATFORM - PARTNERSHIP AIMS TO BUILD UP JOINTLY OWNED PIPELINE TO DELIVER INNOVATIVE, AFFORDABLE AND... From Evotec AG Via AccessWire Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb November 10, 2021 - THE DESIGNATION OF ADDITIONAL PROGRAMMES BY BRISTOL MYERS SQUIBB TRIGGERED PAYMENTS OF IN TOTAL US$ 40 M TO EVOTEC HAMBURG, GERMANY / ACCESSWIRE / November 10, 2021 / Evotec SE (Frankfurt Stock... From Evotec AG Via AccessWire Exposures Product Safety Evotec SE Announces Closing of Public Offering November 09, 2021 HAMBURG, GERMANY / ACCESSWIRE / November 9, 2021 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) announced today the closing of its public offering on 08... From Evotec AG Via AccessWire The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.